Presentations

Documents

Order by : Name | Date | Hits [ Ascendant ]

Genetic Factors in NAFLD: Disease Progression & Hepatocellular Carcinoma Genetic Factors in NAFLD: Disease Progression & Hepatocellular Carcinoma

hot!
Date added: 06/10/2017
Date modified: 06/10/2017
Filesize: 256 Bytes
Downloads: 1033

Oral presentation given by UNEW at the National Cancer Research Institute (NCRI) Cancer Conference, Liverpool, UK, 9th November 2016

Genes and miRNAs: Biological and clinical associations Genes and miRNAs: Biological and clinical associations

hot!
Date added: 01/18/2017
Date modified: 01/18/2017
Filesize: 256 Bytes
Downloads: 1366

Oral presentation given by UNEW at the EASL Monothematic Conference, Riga, Latvia, 12th – 14th May 2016

Fibrosis biology and biomarkers in NASH Fibrosis biology and biomarkers in NASH

hot!
Date added: 02/28/2018
Date modified: 02/28/2018
Filesize: 256 Bytes
Downloads: 783

Oral presentation given by UMC & NB at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017

Fibrogenesis in NAFLD: Mechanism Fibrogenesis in NAFLD: Mechanism

hot!
Date added: 01/18/2017
Date modified: 01/18/2017
Filesize: 256 Bytes
Downloads: 1470

Oral presentation given by UNITO at the EASL Monothematic Conference, Riga, Latvia, 12th – 14th May 2016

Fatty liver disease is associated to increased glucogenic amino acids and decreased de novo... Fatty liver disease is associated to increased glucogenic amino acids and decreased de novo...

hot!
Date added: 08/05/2018
Date modified: 08/05/2018
Filesize: 256 Bytes
Downloads: 458

"Fatty liver disease is associated to increased glucogenic amino acids and decreased de novo alanine synthesis"

Oral presentation given by CNR & UNITO at the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017), Lisbon, Portugal, 15th September 2017

Fattori di rischio della steatosi: marcatori prognostici e diagnostici Fattori di rischio della steatosi: marcatori prognostici e diagnostici

hot!
Date added: 03/07/2017
Date modified: 03/07/2017
Filesize: 6.14 MB
Downloads: 1131

Oral presentation on risk factors of NAFLD given by CNR at the 22nd Italian meeting of the European Ligand Assay Society, Bologna, Italy, 21st November 2016 

European NAFLD Consortia: EPoS, LITMUS & The European NAFLD Registry European NAFLD Consortia: EPoS, LITMUS & The European NAFLD Registry

hot!
Date added: 08/10/2019
Date modified: 08/10/2019
Filesize: 256 Bytes
Downloads: 227

Presentation given by UNEW at the EASL International Liver Congress, Vienna, Austria, 10th - 14th April 2019

Elucidation of metabolic changes in non-alcoholic fatty liver disease and the role of environ... Elucidation of metabolic changes in non-alcoholic fatty liver disease and the role of environ...

hot!
Date added: 12/31/2018
Date modified: 12/31/2018
Filesize: 2.03 MB
Downloads: 223

"Elucidation of metabolic changes in non-alcoholic fatty liver disease and the role of environmental, nutritional and genetic factors"

Oral presentation given by ORU at Analytica, Munich, Germany, 10th - 12th April 2018

Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin... Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin...

hot!
Date added: 03/13/2018
Date modified: 03/13/2018
Filesize: 256 Bytes
Downloads: 666

"Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin Resistance and Liver Histology in Patients with NASH"

Oral presentation given by CNR at the European Group for the study of Insulin Resistance (EGIR) meeting, Dublin, Ireland, 4th - 6th May 2017

Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin... Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin...

hot!
Date added: 03/13/2018
Date modified: 03/13/2018
Filesize: 256 Bytes
Downloads: 754

"Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin Resistance and Liver Histology in Patients with NASH"

Oral presentation given by CNR at the 5th EASD-NAFLD Study Group meeting, Gothenburg, Sweden, 8th - 9th May 2017